Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-04

FDA Approved: OXCARBAZEPINE — Original Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved the generic oxcarbazepine under an Original Application for Bionpharma Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxcarbazepine (Oxcarbazepine)

Snippet

ORIG AP for OXCARBAZEPINE (OXCARBAZEPINE)